slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
236,641-236,700 of 319,975
01
Creatd | Investor Presentation Deck | 11 slidesCreatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations 1 hit
02
The image is a surrealist painting by Mattelson depicting a human figure as a power plug, symbolizing connection or energy.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations 1 hit
03
The slide serves as a visual proof point for the company's asset collection.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · Problem1 hit
04
The slide uses a grid layout to present four distinct asset categories with corresponding imagery and counts.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a visual demonstration of AI object detection and labeling to illustrate the technical capabilities.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
The slide serves as a portfolio or case study gallery demonstrating the company's IP creation capabilities.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Creatd | Investor Presentation Deck | 11 slidesCreatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · Business ModelLoop · Cost Of Inaction1 hit
08
The image is a cover of OMNI magazine from November 1984, likely used to evoke a sense of legacy media and futuristic technology.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
The slide uses a split-column layout to contrast physical archival value with intangible IP value.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a 2x2 grid layout to present the value proposition of the loan.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · The AskLoop · Cost Of Inaction1 hit
11
Creatd | Investor Presentation Deck | 11 slidesCreatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · The Ask1 hit
01
The slide uses a retro, pixelated aesthetic.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations 1 hit
02
The slide uses a historical map and pixelated aesthetic to frame the problem of trade route inefficiency.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Beat · ProblemLoop · Why Now1 hit
03
Historical context slide, likely part of a pitch deck for Christopher Columbus.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Loop · Why Now1 hit
04
The slide uses a historical framing device (March 14, 1491) to present a business case for Columbus's voyage.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Beat · Market SizeLoop · Why Now1 hit
05
The slide uses a historical framing (Christopher Columbus's pitch to the Spanish Crown) to illustrate a business proposal.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Beat · SolutionLoop · Why Now1 hit
06
The slide uses a retro, pixelated aesthetic. The date 'March 14, 1491' is likely a thematic framing device.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Beat · RoadmapLoop · Why Now1 hit
07
The slide uses a classic hierarchical org chart structure to represent historical naval command.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Loop · Why Now1 hit
08
The slide uses a retro, pixelated aesthetic. It maps specific threats to coping mechanisms.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Loop · Why Now1 hit
09
The slide uses a retro, pixelated aesthetic typical of early 1980s computer presentations.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Beat · FinancialsLoop · Why Now1 hit
10
The slide uses a retro, pixelated aesthetic. The date is March 14, 1491.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations Beat · The AskLoop · Why Now1 hit
11
The slide uses a retro, pixelated aesthetic typical of early computer presentations.Forethought | Other Presentation Deck | 11 slides · Christopher Columbus
Deck Investor relations 1 hit
01
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations 1 hit
02
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations 1 hit
03
The slide uses a grid layout to present key company metrics and strategic highlights.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide highlights clinical and commercial milestones for a CAR-T therapy.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
05
Includes Kaplan-Meier survival curve and associated table for refractory patient groups.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
Includes Kaplan-Meier survival curve data.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
09
The chart highlights Carvykti's superior growth curve compared to Kymriah, Yescarta, Tecartus, Breyanzi, and Abecma.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The chart uses a stacked bar format to distinguish between U.S. and OUS (Outside U.S.) sales.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
11
The slide lists specific clinical trial identifiers and study designs for Legend Biotech's pipeline.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
12
The slide uses a map-based visualization to link regional regulatory status with patient population data.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
13
The slide uses a pie chart to show the current split between outpatient and inpatient settings, emphasizing the growth potential for outpatient.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
14
The slide uses a two-column layout to categorize facilities by region (US vs EU).Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
15
The chart is a timeline-based growth curve showing capacity expansion milestones.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
16
The slide uses a timeline to establish market leadership and a list of competitive moats.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Beat · CompetitionLoop · Golden Circle1 hit
17
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
18
The slide uses a matrix-like structure to organize clinical trials by phase and therapeutic area, including both autologous and allogeneic therapies.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
19
The slide combines a feature-benefit breakdown with a linear process flow.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
20
Slide 20 of the deck.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
21
The slide uses a two-column layout to contrast general lung cancer statistics with specific SCLC data.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
22
The slide uses a schematic diagram to illustrate the 'Armored' CAR-T mechanism.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
23
Includes a schematic of the CAR-T construct.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
24
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
25
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
26
Legend Biotech | Investor Presentation Deck | 26 slidesLegend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations 1 hit
18
The slide uses a split-layout comparing M&A criteria on the left with deal rationale and financial metrics on the right.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
19
The slide presents a comparative balance sheet table and a list of strategic capital allocation priorities.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
20
The slide presents three distinct pillars of financial guidance: Revenue, Profitability (Gross Margin/EBITDA), and Cash Flow.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
21
Limbach Holdings | Investor Presentation Deck | 29 slidesLimbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
22
The slide is mostly empty space, likely a template or placeholder.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
23
Includes footnotes regarding rounding and non-GAAP reconciliation.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
24
Data presented in millions; includes segment breakdown (ODR/GCR) for Revenue and Gross Profit.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
25
The slide uses a circular diagram to represent the ESG framework, with supporting bullet points for each pillar.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
26
Includes detailed line-item adjustments such as depreciation, interest, stock-based compensation, and various non-recurring costs.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
27
Includes a disclaimer regarding the use of non-GAAP financial measures at the bottom.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
28
Includes footnotes explaining non-GAAP adjustments and non-cash activities.Limbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit
29
Limbach Holdings | Investor Presentation Deck | 29 slidesLimbach Holdings | Investor Presentation Deck | 29 slides · Limbach Holdings
Conference presentation Investor relations 1 hit